This service evaluates and optimizes an organization’s mix of clinical trials  to ensure a strategic balance of funding sources, study types, and resource use.

For Sites, it helps prioritize trials that align with their capacity, patient population, and financial goals.

For Sponsors and CROs, it ensures stronger alignment with capable, focused Sites that are positioned to deliver better performance and faster enrollment.